Canada Life’s CAMBRIDGE BANCORP CATC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-730
| Closed | -$50K | – | 2099 |
|
|
2024
Q2 | $50K | Sell |
730
-6
| -0.8% | -$390 | ﹤0.01% | 1971 |
|
|
2024
Q1 | $50K | Sell |
736
-24
| -3% | -$1.59K | ﹤0.01% | 2017 |
|
|
2023
Q4 | $52K | Buy |
760
+437
| +135% | +$26.7K | ﹤0.01% | 2044 |
|
|
2023
Q3 | $20K | Hold |
323
| – | – | ﹤0.01% | 2137 |
|
|
2023
Q2 | $18K | Hold |
323
| – | – | ﹤0.01% | 2177 |
|
|
2023
Q1 | $21K | Hold |
323
| – | – | ﹤0.01% | 2208 |
|
|
2022
Q4 | $27K | Buy |
+323
| New | +$27.6K | ﹤0.01% | 2207 |
|
|
2020
Q3 | – | Sell |
-55
| Closed | -$3K | – | 2711 |
|
|
2020
Q2 | $3K | Buy |
55
+6
| +12% | +$316 | ﹤0.01% | 2637 |
|
|
2020
Q1 | $2K | Hold |
49
| – | – | ﹤0.01% | 2667 |
|
|
2019
Q4 | $4K | Buy |
+49
| New | +$3.82K | ﹤0.01% | 2629 |
|
|
2019
Q3 | – | Sell |
-24
| Closed | -$2K | – | 2390 |
|
|
2019
Q2 | $2K | Buy |
24
+2
| +9% | +$165 | ﹤0.01% | 2714 |
|
|
2019
Q1 | $2K | Hold |
22
| – | – | ﹤0.01% | 2483 |
|
|
2018
Q4 | $2K | Buy |
+22
| New | +$1.87K | ﹤0.01% | 2676 |
|
Canada Life's CATC Position: Q3 2024 in Review
Canada Life sold out of CAMBRIDGE BANCORP (CATC) in Q3 2024, closing a stake of 730 shares — an estimated $50K sold.
Canada Life first reported a position in CATC in Q4 2018 and held it in 13 quarters. The position peaked at $52K in Q4 2023. 0 funds tracked by Wall St. Rank hold CATC as of Q3 2024.
- Canada Life reported no remaining CAMBRIDGE BANCORP position as of Q3 2024 after selling out during the quarter.
- Canada Life sold 730 CAMBRIDGE BANCORP shares in Q3 2024, an estimated $50K.
- Canada Life first reported a position in CAMBRIDGE BANCORP in Q4 2018 and held it in 13 quarters.
- Canada Life's CAMBRIDGE BANCORP position peaked at $52K in Q4 2023.
- 0 funds tracked by Wall St. Rank held CAMBRIDGE BANCORP as of Q3 2024.
Based on Canada Life's 13F filing for Q3 2024, filed 13 Nov 2024.